Skip to main content
Have a personal or library account? Click to login
Glucocorticoid-Induced Osteoporosis Cover

Glucocorticoid-Induced Osteoporosis

Archives of Industrial Hygiene and Toxicology
Volume 58 (2007): Issue 1 (March 2007)
By:   
Open Access
|Mar 2007
References

References

  1. American College of Rheumatology Task Force on Osteoporosis Guidelines. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.1996;39:1791-801.
    Open DOISearch in Google Scholar
  2. Mazziotti G, Angeli A, Bilezikian JP, Canalis E, Giustina A. Glucocortcoid-induced osteoporosis: an update.2006;17:144-9.
    Open DOISearch in Google Scholar
  3. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management.1990:112:352-64.
    Open DOISearch in Google Scholar
  4. Shaker JL, Lukert BP. Osteoporosis associated with excess glucocorticoids.2005;34:341-56.
    Open DOISearch in Google Scholar
  5. Reid IR, Grey AB. Corticosteroid osteoporosis.1993;7:573-87.
    Open DOISearch in Google Scholar
  6. Adachi J, Ionnidis G. Primer on corticosteroid-induced osteoporosis. Philadelphia (PA): Lippincott Williams & Wilkins; 2000.
    Search in Google Scholar
  7. Dalle Carbonare L, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis.2001;16:97-103.
    Open DOISearch in Google Scholar
  8. Suda T, Takahashi N, Udagawa N, Jimi E, gillepsie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.1999;20:345-57.
    Open DOISearch in Google Scholar
  9. Canalis E. Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis.1996;81:3441-7.
    Search in Google Scholar
  10. Canalis E. Mechanisms of glucocorticoid-induced osteoporosis.2003;15:454-7.
    Open DOISearch in Google Scholar
  11. Van Staa TP. The patogenesis, epidemiology and management of glucocorticoid-induced osteoporosis.2006;79:129-37.
    Open DOISearch in Google Scholar
  12. Haugeberg G, Uhlig T, Falch JA, Halse JI, Lems WF, Dijkmans BA, Woolf AD. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid arthritis register.2000;43:422-530.
    Open DOISearch in Google Scholar
  13. Spector TD, Hall GM, McCloskey EV, Kanis JA. Risk of vertebral fracture in women with rheumatoid arthritis.1993;306:558.
    Open DOISearch in Google Scholar
  14. Huusko TM, Korpela M, Karppi P, Avikainen V, Kautiainen H, Sulkava R. Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland.2001;60:521-2.
    Open DOISearch in Google Scholar
  15. Van Staa TP, Leufkens HG, Abenhaim L, Begaud B, Zhang B, Cooper C. Use of oral corticosteroids in the United Kingdom.2000;93:105-11.
    Open DOISearch in Google Scholar
  16. Filipčić A, Fotez I, Varnai VM, Babić-Naglić Đ, Ćurković B. Primjena lijekova u bolesnika s reumatoidnim artritisom u realnom životu.2004;51:68.
    Search in Google Scholar
  17. Van Staa TP, Abenhaim L, Cooper C, Zhang B, Leufkens HG. Public health imapct of adverse bone effects of oral corticosteroids.2001;51:601-7.
    Open DOISearch in Google Scholar
  18. Van Staa TP, Laan RF, Barton I, Cohen S, Reid DM, Cooper C. Predictors and bone density treshold for vertebral fracture in patients using oral glucocorticosteroids.2003;48:3224-9.
    Open DOISearch in Google Scholar
  19. Kanis JA, Johansson H, Oden A, Johnell O, De Laet C, Eisman JA, Mc Closkey EV, Mellstrom D, Melton LJ 3rd, Pols HA, Reeve J, Silman AJ, Tenenhouse A. A meta-anlysis of prior corticosteroid use and fracture risk.2004;19:893-9.
    Open DOISearch in Google Scholar
  20. Van Staa TP, Leufkens HGM, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.2002;13:777-87.
    Open DOISearch in Google Scholar
  21. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update.2001;44:1496-503.
    Open DOISearch in Google Scholar
  22. Haugeberg G, Orstavik RE, Kvien TK. Effects of rheumatoid arthritis on bone.2003;15:469-75.
    Open DOISearch in Google Scholar
  23. Sambrook PN. How to prevent steroid induced osteoporosis.2005;64:176-8.
    Open DOISearch in Google Scholar
  24. Laktašić-Žerjavić N, Ćurković B, Crnčić N, Babić-Naglić Đ. Osteoporosis in rheumatoid arthritis: a comparison between corticosteroid treated and non treated patients.2006;73:225-6.
    Search in Google Scholar
  25. Royal College of Physicians, National osteoporosis Society, Bone and Tooth Society of Great Britain. Glucocorticoid-induced osteoporosis - guidelines for prevention and treatment. London: Royal College of Physicians; 2002.
    Search in Google Scholar
  26. Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG. Alendronate for the prevention and treatment of glucocorticoid induced osteoporosis.1998;339:292-9.
    Open DOISearch in Google Scholar
  27. Adachi JD, Saag KG, Delmas PD, Liberman UA, Emkey RD, Seeman E, Lane NE, Kaufman JM, Poubelle PE, Hawkins F, Correa-Rotter R, Menkes CJ, Rodriguez-Portales JA, Schnitzer TJ, Block JA, Wing J, McIlvwain HH, Westhovens R, Brown J, Melo-Gomes JA, Gruber BL, Yanover MJ, Leite MO, Siminoski KG, Nevitt MC, Sharp JT, Malice MP, Dumortier T, Czachur M, Carofano W, Daifotis A. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids.2001;44:202-11.
    Open DOISearch in Google Scholar
  28. Wallach S, Cohen S, Reid DM, Hughes RA, Hosking DJ, Laan RF, Doherty SM, Maricic M, Rosen C, Brown J, Barton I, Chines AA. Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy.2000;87:277-85.
    Open DOISearch in Google Scholar
  29. Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis.1998;102:1627-33.
    Open DOISearch in Google Scholar
  30. Mužić V, Babić-Naglić Đ, Potočki K, Ćurković B. Osteoporotic vertebral fractures in inflammatory rheumatic patients.2006;7(suppl. I):40-1.
    Search in Google Scholar
  31. Zochling J, Nash P, Riordan J, Sambrook N. Use of corticosteroids and bone-active medications in clinical practice.2006;9:37-42.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10004-007-0004-8 | Journal eISSN: 1848-6312 (formerly 0004-1254) | Journal ISSN: 0004-1254
Journal RSS Feed
Language: English
Page range: 19 - 24
Published on: Mar 28, 2007
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Keywords:
drug-induced osteoporosis,
osteoclastogenesis,
osteoporosis management,
pathophysiology,
risk of fractures
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2007 Božidar Čurković, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons License.

Volume 58 (2007): Issue 1 (March 2007)
Previous article
Next article